Predictors of sustained virological response to a 48-week course of pegylated interferon alfa-2a and ribavirin in patients infected with hepatitis C virus genotype 4
Open Access
- 1 January 2009
- journal article
- Published by King Faisal Specialist Hospital and Research Centre in Annals of Saudi Medicine
- Vol. 29 (1) , 4-14
Abstract
BACKGROUND AND OBJECTIVES: Knowledge of the predictors of sustained viral response (SVR) to pegylated interferon (PEG-INF) alfa-2a and ribavirin (RBV) therapy in patients with hepatitis C genotype-...Keywords
This publication has 65 references indexed in Scilit:
- Sustained virologic response to peginterferon α-2a and ribavirin in 335 patients with chronic hepatitis C: A tertiary care center experienceSaudi Journal of Gastroenterology, 2008
- Pegylated interferon alpha-2b plus ribavirin in patients with genotype 4 chronic hepatitis C: The role of rapid and early virologic responseHepatology, 2007
- Pretreatment Sequence Diversity Differences in the Full-Length Hepatitis C Virus Open Reading Frame Correlate with Early Response to TherapyJournal of Virology, 2007
- Sustained Viral Response to Pegylated Interferon α-2b and Ribavirin in Chronic Hepatitis C Refractory to Prior TreatmentDigestive Diseases and Sciences, 2006
- Serum alpha-fetoprotein levels in patients with advanced hepatitis C: Results from the HALT-C TrialJournal of Hepatology, 2005
- Peginterferon α‐2b plus ribavirin compared with interferon α‐2b plus ribavirin for initial treatment of chronic hepatitis C in Saudi patients commonly infected with genotype 4Liver International, 2004
- Early viral kinetics and treatment outcome in combination of high‐dose interferon induction vs. pegylated interferon plus ribavirin for naïve patients infected with hepatitis C virus of genotype 1b and high viral loadJournal of Medical Virology, 2004
- Meta‐analysis: a randomized trial of peginterferon plus ribavirin for the initial treatment of chronic hepatitis C genotype 4Alimentary Pharmacology & Therapeutics, 2004
- Treatment of Hepatitis C Virus Genotype 4–Related CirrhosisJournal of Clinical Gastroenterology, 2002
- Treatment of chronic hepatitis C genotype IV with interferon–ribavirin combination in Saudi Arabia: a multicentre studyJournal of Viral Hepatitis, 2000